Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Meropenem Intravenous
Determining the interaction of Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and Meropenem Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
Generic Name: meropenem
Brand name: Merrem, Merrem Novaplus
Synonyms: Meropenem
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Merrem
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Merrem IV
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Merthiolate
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Meruvax II
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Mesalamine
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Mesalamine Controlled-Release Capsules
- Meropenem Intravenous-Kitabis Pak
- Meropenem Intravenous-Kitabis Pak inhalation
- Meropenem Intravenous-Klofensaid II
- Meropenem Intravenous-Klonopin
- Meropenem Intravenous-Klonopin Wafer
- Meropenem Intravenous-Klonopin Wafers